ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/05/31 | 1,960 | 1,987 | 1,960 | 1,987 | +38 | +1.9% | 72,400 |
2024/05/30 | 1,936 | 1,949 | 1,921 | 1,949 | +10 | +0.5% | 50,500 |
2024/05/29 | 1,960 | 1,966 | 1,935 | 1,939 | -22 | -1.1% | 45,000 |
2024/05/28 | 1,969 | 1,969 | 1,957 | 1,961 | +1 | +0.1% | 24,900 |
2024/05/27 | 1,959 | 1,965 | 1,947 | 1,960 | +7 | +0.4% | 40,100 |
2024/05/24 | 1,940 | 1,958 | 1,938 | 1,953 | +3 | +0.2% | 38,700 |
2024/05/23 | 1,957 | 1,968 | 1,944 | 1,950 | -9 | -0.5% | 74,600 |
2024/05/22 | 1,989 | 1,989 | 1,957 | 1,959 | -21 | -1.1% | 52,900 |
2024/05/21 | 2,010 | 2,010 | 1,980 | 1,980 | -21 | -1% | 70,700 |
2024/05/20 | 2,009 | 2,017 | 2,001 | 2,001 | -8 | -0.4% | 36,400 |
2024/05/17 | 1,995 | 2,013 | 1,991 | 2,009 | +9 | +0.5% | 42,900 |
2024/05/16 | 2,032 | 2,035 | 1,990 | 2,000 | -25 | -1.2% | 70,000 |
2024/05/15 | 2,065 | 2,067 | 2,025 | 2,025 | -20 | -1% | 44,600 |
2024/05/14 | 2,039 | 2,068 | 2,030 | 2,045 | +6 | +0.3% | 61,400 |
2024/05/13 | 2,017 | 2,042 | 2,009 | 2,039 | +38 | +1.9% | 87,800 |
2024/05/10 | 2,059 | 2,071 | 1,996 | 2,001 | -108 | -5.1% | 226,400 |
2024/05/09 | 2,115 | 2,116 | 2,091 | 2,109 | +10 | +0.5% | 68,500 |
2024/05/08 | 2,105 | 2,107 | 2,090 | 2,099 | +4 | +0.2% | 48,000 |
2024/05/07 | 2,111 | 2,111 | 2,085 | 2,095 | -24 | -1.1% | 43,300 |
2024/05/02 | 2,102 | 2,130 | 2,098 | 2,119 | +21 | +1% | 58,300 |
2024/05/01 | 2,082 | 2,106 | 2,075 | 2,098 | +5 | +0.2% | 34,400 |
2024/04/30 | 2,076 | 2,099 | 2,056 | 2,093 | +34 | +1.7% | 52,100 |
2024/04/26 | 2,063 | 2,064 | 2,033 | 2,059 | +11 | +0.5% | 31,400 |
2024/04/25 | 2,067 | 2,072 | 2,044 | 2,048 | -15 | -0.7% | 43,500 |
2024/04/24 | 2,058 | 2,072 | 2,056 | 2,063 | +6 | +0.3% | 26,900 |
2024/04/23 | 2,056 | 2,065 | 2,047 | 2,057 | -1 | ±0% | 17,900 |
2024/04/22 | 2,035 | 2,061 | 2,035 | 2,058 | +45 | +2.2% | 32,800 |
2024/04/19 | 2,039 | 2,039 | 1,996 | 2,013 | -28 | -1.4% | 49,900 |
2024/04/18 | 2,025 | 2,052 | 2,023 | 2,041 | +16 | +0.8% | 38,400 |
2024/04/17 | 2,060 | 2,060 | 2,025 | 2,025 | -38 | -1.8% | 50,900 |
2024/04/16 | 2,080 | 2,082 | 2,058 | 2,063 | -25 | -1.2% | 47,700 |
2024/04/15 | 2,090 | 2,090 | 2,076 | 2,088 | -4 | -0.2% | 31,400 |
2024/04/12 | 2,085 | 2,100 | 2,079 | 2,092 | +7 | +0.3% | 37,900 |
2024/04/11 | 2,078 | 2,093 | 2,071 | 2,085 | -13 | -0.6% | 35,000 |
2024/04/10 | 2,104 | 2,110 | 2,096 | 2,098 | +3 | +0.1% | 30,500 |
2024/04/09 | 2,105 | 2,105 | 2,085 | 2,095 | ±0 | ±0% | 38,900 |
2024/04/08 | 2,087 | 2,101 | 2,075 | 2,095 | +26 | +1.3% | 50,500 |
2024/04/05 | 2,048 | 2,069 | 2,038 | 2,069 | +10 | +0.5% | 39,900 |
2024/04/04 | 2,070 | 2,071 | 2,055 | 2,059 | -16 | -0.8% | 57,500 |
2024/04/03 | 2,075 | 2,084 | 2,056 | 2,075 | -11 | -0.5% | 47,500 |
2024/04/02 | 2,126 | 2,130 | 2,078 | 2,086 | -40 | -1.9% | 73,400 |
2024/04/01 | 2,146 | 2,156 | 2,120 | 2,126 | -6 | -0.3% | 58,200 |
2024/03/29 | 2,124 | 2,146 | 2,124 | 2,132 | +16 | +0.8% | 54,800 |
2024/03/28 | 2,161 | 2,161 | 2,116 | 2,116 | -63 | -2.9% | 99,300 |
2024/03/27 | 2,170 | 2,192 | 2,170 | 2,179 | +13 | +0.6% | 130,700 |
2024/03/26 | 2,164 | 2,184 | 2,148 | 2,166 | -10 | -0.5% | 83,300 |
2024/03/25 | 2,190 | 2,205 | 2,176 | 2,176 | -27 | -1.2% | 100,600 |
2024/03/22 | 2,210 | 2,210 | 2,188 | 2,203 | +14 | +0.6% | 49,600 |
2024/03/21 | 2,212 | 2,213 | 2,183 | 2,189 | -8 | -0.4% | 87,500 |
2024/03/19 | 2,181 | 2,200 | 2,176 | 2,197 | +10 | +0.5% | 46,600 |
1~
50
件表示中 / 3467件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 198,700円 | +9.6% | +17.5% | 2.32% | 11.22倍 | 1.10倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 220,300円 | +52.1% | +23.3% | 0.00% | 15.60倍 | 3.26倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
鳥居薬 | 378,500円 | +7.3% | +16.8% | 3.17% | 22.64倍 | 0.89倍 |
|
JT傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗HIV薬の販売権喪失が直撃 |
栄研化 | 209,700円 | +7.6% | +57.5% | 2.53% | 16.20倍 | 1.59倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割弱。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 57,400円 | -3.7% | -36.7% | 3.48% | 19.36倍 | 1.30倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム